Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species (original) (raw)

Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor

Biochemical and Biophysical Research Communications, 1989

Captopril does not scavenge superoxide: Captopril prevents O2⨪ production by chelating copper

Archives of Biochemistry and Biophysics, 1991

Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors

Pierre Van Antwerpen

European journal of pharmacology, 2006

View PDFchevron_right

Angiotensin-Converting Enzyme Inhibitor Captopril Reverses the Adverse Cardiovascular Effects of Polymerized Hemoglobin

Udho Thadani

Antioxidants & Redox Signaling, 2014

View PDFchevron_right

Captopril: a free radical scavenger

James Mclay

British Journal of Clinical Pharmacology, 1989

View PDFchevron_right

A Study of the Antioxidant Effects of Iranian Captopril on Patients with Hypertension and Heart Failure

M. Sadeghi

2010

View PDFchevron_right

Effect of Time and Dose on Angiotensin Converting Enzyme during Captopril Treatment in the Rat

T. Forslund

Acta Pharmacologica et Toxicologica, 1983

View PDFchevron_right

Impact of captopril on cardiac mitochondrial function in an in-vivo animal model of atherosclerosis

Zvezdana Kojic

Acta veterinaria, 2006

View PDFchevron_right

The In Vitro Effects of Captopril on the Levels of Lipid Peroxidation and Glutathione of Erythrocytes in Type II Diabetes

Özer Açbay

Journal of Basic and Clinical Physiology and Pharmacology, 1995

View PDFchevron_right

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells

William Weglicki

Biochemical Pharmacology, 1990

View PDFchevron_right

Captopril ameliorates myocardial and hematological toxicities induced by adriamycin

Othman Shabanah

IUBMB Life, 1998

View PDFchevron_right

Superoxide dismutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver

Leon Ferder

FEBS Letters, 1995

View PDFchevron_right

Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta

Manjeet Singh

Molecular and Cellular Biochemistry, 1998

View PDFchevron_right

Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: Interaction with low dose acetylsalicylic acid

Dimitrios Tsikas

British Journal of Clinical Pharmacology, 2003

View PDFchevron_right

Decrease of Serum Angiotensin Converting Enzyme Activity after Discontinuation of Captopril Treatment

T. Forslund

Acta Pharmacologica et Toxicologica, 1983

View PDFchevron_right

The Role of Antioxidant Drugs in Oxidative Injury of Cardiovascular Tissue

Jay Kramer

1999

View PDFchevron_right

Can angiotensin-converting enzyme inhibitors interfere with the free radicals? Measurement of antioxidant capacity using DPPH radical reduction examined by UV-VIS method

Paweł Ramos

Acta Poloniae Pharmaceutica - Drug Research, 2019

View PDFchevron_right

Effect of a short-term captopril treatment on serum and tissue angiotensin I-converting enzyme activity from four mammalian species. Differences using diamide in the in vitro assay

Noel Cruz

Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 1993

View PDFchevron_right

RENIN-ANGIOTENSIN SYSTEM AND LIPID PEROXIDATION

Anna Tolekova

2005

View PDFchevron_right

Effect of captopril on serum lipid levels and cardiac mitochondrial oxygen consumption in experimentally-induced hypercholesterolemia in rabbits

Kristina Gopcevic

Physiological research / Academia Scientiarum Bohemoslovaca, 2011

View PDFchevron_right

Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction

Dipak Das

The Annals of Thoracic Surgery, 1991

View PDFchevron_right

Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers

Sara Bonomo

American Heart Journal, 2009

View PDFchevron_right

Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats

Stanley Stead

Hypertension, 2005

View PDFchevron_right

Angiotensin-converting enzyme inhibition and angiotensin AT 1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity

Ibrahim Gomaa

Pharmacological Research, 2009

View PDFchevron_right

Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats

T. Forslund

Acta pharmacologica et toxicologica, 1981

View PDFchevron_right

Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues

Felipe Inserra

American Journal of …, 2000

View PDFchevron_right

Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril

Thomas Unger

European Journal of Pharmacology, 1981

View PDFchevron_right

The effect of captopril on membrane bound enzymes in ischemia–reperfusion injury

cansu isbir

Cardiovascular Surgery, 2000

View PDFchevron_right

Acute and Chronic Effects of Perindopril on Tissue Angiotensin Converting Enzyme Activity

Frederick Mendelsohn

American Journal of Hypertension, 1991

View PDFchevron_right

Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species (original) (raw)

Related papers